A Multiple Ascending Dose Study of ETC-1002 in Subjects With Mild Dyslipidemia

NCT01105598 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

53

Enrollment

INDUSTRY

Sponsor class

Conditions

Mild Dyslipidemia

Interventions

DRUG: ETC-1002 or placebo
DRUG: ETC-1002 or placebo
DRUG: ETC-1002 or placebo

Sponsor

Esperion Therapeutics, Inc.